Company Filing History:
Years Active: 2015
Title: Inventor Profile: Michelle Leigh Totten
Introduction
Michelle Leigh Totten is an accomplished inventor based in Fishers, Indiana, known for her innovative contributions to veterinary medicine. With a focus on improving the health and well-being of pets, her work has led to the development of a unique product designed specifically for cats.
Latest Patents
Totten holds a patent for a groundbreaking invention titled "Single Dose Oral Formulations and Methods for Treatment of Cats with Ectoparasiticidal Spinosad." This invention offers a single-dose oral formulation of spinosad, which provides extended control of infestations in cats. The formulation is designed to deliver a predictable dose of spinosad suitable for administration once every 30 days, making it a convenient option for pet owners. Additionally, the patent outlines methods for using this effective treatment to enhance feline care.
Career Highlights
Michelle is currently employed at Eli Lilly and Company, where she utilizes her expertise in pharmacology and veterinary science to develop innovative solutions. Her work is instrumental in creating products that prioritize the health and safety of animals while ensuring ease of application for their owners.
Collaborations
Throughout her career, Totten has collaborated with various professionals in the field, including her coworkers Kari Lynette Riggs and Daniel Earl Snyder. These partnerships have bolstered her research efforts and contributed to the influential nature of her work within the industry.
Conclusion
Michelle Leigh Totten exemplifies dedication and innovation in her contributions to veterinary medicine. Her patent for a single-dose spinosad formulation marks an important step forward in the treatment of parasitic infestations in cats, showcasing her commitment to enhancing animal health. As she continues her work at Eli Lilly and Company, Totten is sure to inspire future innovations that improve the quality of life for pets everywhere.